Osaic Holdings’s Serina Therapeutics SER Stock Holding History
Bought
Maintained
Sold
Other funds holding SER
SCM
VCM
WA
KP
VFT
AWE
Osaic Holdings's SER Position: Q1 2026 in Review
Osaic Holdings increased its Serina Therapeutics (SER) stake by 49,950% in Q1 2026, buying an estimated $2.2K and bringing the position to 1,001 shares worth $1.94K. The position accounts for ﹤0.01% of the portfolio, ranked #7058.
Osaic Holdings first reported a position in SER in Q1 2020 and has held it in 25 quarters since. The position peaked at $6K in Q1 2022. 25 funds tracked by Wall St. Rank hold SER as of Q1 2026.
- Osaic Holdings held 1,001 shares of Serina Therapeutics worth $1.94K as of Q1 2026.
- Osaic Holdings bought 999 Serina Therapeutics shares in Q1 2026, an estimated $2.2K.
- Serina Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7058 holding.
- Osaic Holdings first reported a position in Serina Therapeutics in Q1 2020 and has held it in 25 quarters since.
- Osaic Holdings's Serina Therapeutics position peaked at $6K in Q1 2022.
- 25 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.